ResMed | RMD - Zahlungsmittel Und Äquivalente

Aktienkurs
227.97
Täglich Wechseln
1.98 0.88%
Monatlich
-9.40%
Jährlich
2.27%
Q1 Prognose
219.21




Zahlungsmittel Und Äquivalente Veränderung Datum
Ansell USD 238.3M 674M 2025-06
Artivion USD 64.91M 8.52M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Baxter International USD 1.97B 240M 2025-12
Cochlear AUD 275.7M 107.4M 2025-06
Cooper Companies USD 110.6M 14.3M 2025-09
CSL USD 2.16B 633M 2025-06
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Fisher Paykel Healthcare NZD 89.9M 13.3M 2022-06
Globus Medical USD 526.16M 154.39M 2025-12
Haemonetics USD 363.37M 66.94M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Idexx Laboratories USD 180.07M 28.1M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Philips EUR 1.91B 90M 2025-09
Ramsay Health Care AUD 784.4M 443.3M 2025-06
ResMed USD 1.42B 33.22M 2025-12
Sigma Healthcare AUD 16.65M 3.68M 2023-01
Sonic Healthcare AUD 645M 25.39M 2024-06
Steris USD 423.7M 104.5M 2025-12
Teleflex USD 354M 100.3M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12